ELAC2 and hypertrophic cardiomyopathy: Although pathogenic biallelic ELAC2 mutations in patients are associated with psychomotor delay, hypotonia, and hypertrophic cardiomyopathy (67, 68), it is not clear which phenotypes are driven by mitochondrial dysfunction or defects in maintaining specific nuclear tRNA isoacceptor pools.